In Brief

23
Herpesviruses have evolved elegant strategies to dampen the host anti-viral responses. Zhang et 24 al. discover a unique mechanism by which herpesviruses evade SAMHD1-mediated host 25 defenses through phosphorylation, expanding the functional repertoire of viral protein kinases in 26 herpesvirus biology 27 28 29
Abstract
30
To ensure a successful infection, herpesviruses have developed elegant strategies to 31 counterbalance the host anti-viral responses. Sterile alpha motif and HD domain 1 (SAMHD1) 32 was recently identified as an intrinsic restriction factor for a variety of viruses. Aside from 33 human immunodeficiency virus 2 (HIV-2) and the related simian immunodeficiency virus (SIV) 34
Vpx proteins, the direct viral countermeasures against SAMHD1 restriction remain unknown.
35
Using Epstein-Barr virus (EBV) as a primary model, we discovered that SAMHD1-mediated 36
anti-viral restriction is antagonized by EBV BGLF4, a member of the conserved viral protein 37 kinases encoded by all herpesviruses. Mechanistically, we found that BGLF4 phosphorylates 38 SAMHD1 and thereby inhibits its dNTPase activity. We further demonstrated that the targeting 39 of SAMHD1 for phosphorylation is a common feature shared by beta-and gamma-40 herpesviruses. Together, our findings uncover a unique immune evasion mechanism whereby 41 herpesviruses exploit the phosphorylation of SAMHD1 to thwart host defenses.
Introduction
48
Human herpesviruses are ubiquitous pathogens that establish lifelong persistent infections and 49 are associated with a variety of diseases ranging from cold sores to mononucleosis, birth defects, 50 and cancers. During a long period of co-evolution with their hosts, these viruses have established 51 multiple strategies to combat the cellular defense systems. The eight human herpesviruses 52 discovered to date are classified into three subfamilies, alpha-, beta-and gamma-herpesviruses.
53
The alpha-herpesviruses consist of herpes simplex 1 and 2 (HSV-1 and HSV-2) and varicella-54 zoster virus (VZV); the beta-herpesviruses include human cytomegalovirus (HCMV), human 55 herpesviruses 6 (HHV-6) and human herpesvirus 7 (HHV-7); and the gamma-herpesviruses are 56
Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) (Gershburg and 57 Pagano, 2008; Li and Hayward, 2013) . Although these herpesviruses express a limited number of 58 unique latency-associated genes, they each encode a large number of functionally conserved lytic 59 genes that are critical for efficient virus replication and spread. Among the conserved lytic gene 60 products are the orthologous serine/threonine protein kinases, namely HSV-1/2 UL13, VZV 61 ORF47, HCMV UL97, HHV-6/7 U69, EBV BGLF4 and KSHV ORF36 (Gershburg and (Fig 1B, lanes 4-6) . In contrast, the phosphorylation of SAMHD1 was even decreased with the 133 same treatment in the vector control cells (Fig 1B, lanes 1-3) . Our previous study demonstrated 134 that EBV protein kinase BGLF4 is a Small Ubiquitin-like Modifier (SUMO) binding protein.
135
The SUMO binding-deficient mutant BGLF4 could not trigger the DNA damage response 136 although the BGLF4 kinase activity was not affected in vitro (Li et al., 2012 To further test whether BGLF4-triggered phosphorylation of SAMHD1 is physiologically 149 relevant during EBV lytic replication, we monitored the phosphorylation of SAMHD1 in 150 lytically induced Akata-BX1 (EBV+) B cells. As a control, the same IgG crosslinking treatment 151 was also applied to Akata-4E3 (EBV-) B cells. Consistent with the results from BGLF4-152 expressing cells (Fig 1B) , we observed a time-dependent increase of phospho-SAMHD1 during 153 the course of EBV lytic reactivation, which correlates nicely with the BGLF4 expression level 154 (Fig 2A, lanes 1-4) . In contrast, the phospho-SAMHD1 level gradually decreased in Akata-4E3 155 (EBV-) B cells following the anit-IgG treatment (Fig 2A, lanes 5-8) . In addition to the major 156 phospho-SAMHD1 band (72 kDa) (Fig 2A, arrow head) , we also noticed a 69 kDa band ( Fig  157  2A, EBV BGLF4 inhibits SAMHD1 dNTPase activity through phosphorylation. 241 We hypothesized that EBV protein kinase BGLF4 can alleviate the anti-viral activity of 242 SAMHD1 through phosphorylation. To get mechanistic insights into how BGLF4 regulates 243 SAMHD1, we measured the dNTPase activity of SAMHD1 and phospho-SAMHD1 triggered by 244 BGLF4. SAMHD1 was first incubated with BGLF4, kinase dead BGLF4 (BGLF4-KD), 245 CDK1/CyclinB or buffer control and then SAMHD1 and phospho-SAMHD1 were activated by 246 incubating with GTP and a mixture of all dNTP at equal concentration. Subsequently, each 247 individual dNTP was added to the activated SAMHD1 mixture for testing SAMHD1's dNTPase 248 activity. Interestingly, we found that phospho-SAMHD1 triggered by BGLF4 and CDK1/Cyclin 249 B shows reduced dCTPase and dTTPase activity while the dATPase and dGTPase activity was 250 less affected (Fig 5) . The results suggested that EBV BGLF4 promotes viral replication through 251 selectively inhibiting SAMHD1's dNTPase activity. 252 253
Common targeting of SAMHD1 by the conserved herpesvirus protein kinases (CHPKs) 254
The eight human herpesviruses diverged around 100 to 200 million years ago, but they each 255 encode a CHPK (McGeoch et al., 1995) . Because the kinase domain of EBV BGLF4 shares high 256 sequence homology with other CHPKs (Fig 6A) , we reasoned that the targeting of SAMHD1 257 might be a common feature for all CHPKs. To test this possibility, we transfected 7 CHPKs 258 representative of the alpha-, beta-and gamma-herpesvirus subfamilies into 293T cells and 259 examined the phosphorylation status of endogenous SAMHD1 in individual CHPK-transfected 260 cells. Interestingly, we found that wild-type CHPKs from all beta-and gamma-herpesviruses 261 (HHV-6/7 U69, HCMV UL97, EBV BGLF4, and KSHV ORF36) induced a strong 262 phosphorylation of SAMHD1 compared to their corresponding kinase-dead (KD) mutants and 263 non-transfection controls (Fig 6B, p-SAMHD1 (T592) blot, lanes 3, 5, 7, 9 and 11 vs lanes 4, 6, 264 8, 10, 12 and 13). In contrast, the alpha-herpesvirus CHPKs (HSV-1 UL13 and VZV ORF47) 265 were unable to induce SAMHD1 phosphorylation on T592 (Fig 6B, lanes 1 and 2) and 11). Kinase-dead (KD) HHV-6 U69 and EBV BGLF4 preserved the interactions with 280 SAMHD1 (Fig 6C, lanes 4 and 10) , suggesting that the kinase activity was not required for the 281 interaction. We detected weak or no interactions for SAMHD1 with HSV1 UL13, HCMV 282 UL97/UL97 KD mutant and KSHV ORF36 KD mutant, possibly due to their low expression 283 levels compared to other viral kinases (Fig 6C, lanes 6 and 12) .
285
To further test whether other CHPKs directly phosphorylate SAMHD1, we performed in vitro 286 kinase assays using purified CHPKs from HCMV and HSV-1. We found that the wild-type 287 HCMV protein kinase UL97, but not the kinase-dead (KD) mutant, triggered a strong 288 phosphorylation of SAMHD1 on T592, similar to that induced by EBV BGLF4 and 289 CDK1/Cyclin B (Fig 7A, lanes 1, 2 and 8 ). In contrast, we didn't detect the phosphorylation 290 signal in reactions containing wild-type HSV-1 UL13 in vitro (Fig 7A, lane 4) . To test whether 291 UL97-induced phosphorylation of SAMHD1 is physiologically relevant during HCMV infection, 292
we monitored the phosphorylation of SAMHD1 in HCMV infected cells. As show in Fig 7B, 
293
HCMV infection also triggered the phosphorylation of SAMHD1 on T592. In addition, we also 294 confirm the previous observation that HCMV infection lead to an increase in CDK1 protein level 295 (Gill et al., 2012) . These results suggest that HCMV infection may trigger the phosphorylation of 296 SAMHD1 by both the viral protein kinase UL97 and the cellular CDK1. 297 298
Taken together, our results suggested that antagonizing SAMHD1-mediated anti-viral activity by 299 phosphorylation is evolutionarily conserved for beta-and gamma-herpesviruses. 300 301 302
Discussion
303
The alpha-, beta-and gamma-herpesviruses have co-evolved with human over long periods of 304 time (McGeoch et al., 1995 SAMHD1 depletion leads to a significant increase in viral replication for EBV (Fig 3 and Fig  315  S1 ). We have demonstrated that most CHPKs counteract the restriction of SAMHD1 by 316 phosphorylation, indicating that beta-and gamma-herpesviruses have evolved within their 317 conserved kinase an anti-SAMHD1 mechanism to foster viral DNA replication. kinase BGLF4 phosphorylates SAMHD1 and inhibits its dCTPase and dTTPase activity in vitro 332 (Fig 5) . During herpesvirus lytic reactivation, the massive viral DNA replication may require a 333 large amount of dNTPs. Therefore, the CHPKs induced phosphorylation of SAMHD1 would 334 ensure the dNTPs supply for viral DNA replication. 335 336
Because T592 of SAMHD1 is the target site of cellular CDK1 and CDK2, our results further 337 support the previous observation that CDK-like activity is shared by beta-and gamma-338 herpesvirus CHPKs (Kuny et al., 2010) . Although only CHPKs form beta-and gamma-339 herpesviruses triggered the phosphorylation of SAMHD1 on T592, the interaction of alpha-340 herpesvirus CHPKs with SAMHD1 suggested that these kinases may also regulate SAMHD1 341 activity without affecting T592 phosphorylation level or with phosphorylation on different sites 342 (Figs 6 and S2) For SAMHD1 purification from E. coli, the pGEX-5x-2-SAMHD1 plasmid was transformed into 456 competent E.coli BL21. The transformed bacterial were then cultured in LB media at 37 To generate phospho-SAMHD1 for dNTPase activity assay, SAMHD1 was in vitro 474 phosphorylated using EBV BGLF4. CDK1/Cyclin B was used as a positive control. The kinase-475 dead BGLF4 and buffer were included as negative controls. In a phosphorylation reaction, full-476 length SAMHD1 was incubated at a ratio of 50:1 (w/w) with the kinases in 10 mM Tris-HCl pH 477 7.5, 150 mM NaCl, 5 mM MgCl2, 0.5 mM TCEP and 2mM ATP. The reaction was initiated by 478 the addition of SAMHD1 and incubated for 6 hours at 4°C. The phosphorylation of SAMHD1 on 479 T592 was confirmed by Western Blot (Arnold et al., 2015) .
In vitro dNTPase activity assay 482
All SAMHD1 dNTPase activity assays were performed in a reaction buffer (100 l per reaction) 483 containing 50 mM Tris-HCl, pH 7.5, 150 Mm NaCl, 5 mM MgCl2 and 0.5 mM TCEP.
484
Recombinant SAMHD1 was phosphorylated by BGLF4 or CDK1 in vitro. Non-phosphorylated 485 SAMHD1 was similarly processed by incubating with kinase-dead BGLF4 (BGLF4-KD) or 486
Buffer control. Then phosphorylated and non-phosphorylated SAMHD1 (1 M) were converted 487 to GTP-bound dimer by adding 1mM GTP for 1 min. SAMHD1 dimer was further activated by 488 adding dNTP mixture (12.5 M each) for 1 min. The mixture was diluted 10-fold and the 489 substrate dCTP, dTTP, dATP or dGTP (100 M) is added for 0 to 240 min at room temperature.
490
The reaction samples were collected at 0, 120 and 240 min and quenched by 10-fold dilution into 491 ice cold buffer containing 10 mM EDTA, followed by spinning through an Amicon Ultra 0.5 ml 492 10 kDa filter at 16000 xg for 20 min (Jang et al., 2016; Tang et al., 2015) .
Deproteinized samples were analyzed by HPLC using a Synergi C18 Column 150 × 4.6mm 495 (Phenomenex). The column was pre-equilibrated in 20mM ammonium acetate, pH 4.5 (buffer 496 A). Injected samples (100 l) were eluted with a linear methanol gradient over 14 min at a flow 497 rate of 1 mL/min. The dN yields were quantified by integration of the calibrated UV absorption 498 peak at 260 nm. 72 hrs. Stocks of virus TS15-rN were prepared and infectious titers determined as described 515 previously (Cui et al., 2012) . 516 517 518
Virus Titration 519 EBV titers were determined using a Raji cell infection assay (Li et al., 2011; Meng et al., 2010) . 520
Briefly, GFP-EBV recombinant virus was harvested from lytically induced Akata BX1 cells 521 carrying sgRNAs targeting SAMHD1 or non-targeting control sgRNA. Raji cells (2 × 10 5 in 1 522 ml medium/well in 24-well plates) was infected with the GFP-virus and phorbol-12-myristate-523 13-acetate (TPA) (20 ng/ml) and sodium butyrate (3 mM) were added 24 h later. After a further 524 24hr, the GFP-positive Raji cells were scored using a fluorescence microscope. The number of 525 green Raji cells was used to determine the concentration of infectious virus particles. 526 527 528 EBV DNA Detection 529
To measure cell associated viral DNA, total genomic DNA was extracted using the Genomic 530 DNA Purification Kit (Cat# A1120, Promega). The relative viral genome copy numbers were 531 determined by quantitative PCR (qPCR) using primers to BALF5 gene normalized by -actin.
532
Primers sequences are: RL0062, 5'-agtccttcttggctagtctgttgac-3' for BALF5-F; RL0063, 5'-533 ctttggcgcggatcctc-3' for BALF5-R; RL0066, 5'-tggacttcgagcaagagatg-3' for -actin-F; RL0067, 534 5'-gaaggaaggctggaagagtg-3' for -actin-R. induce EBV lytic reactivation. SAMHD1 protein and phosphorylation levels, the accumulation 591 of EBV ZTA and BGLF4, and the CDK1 protein level were analyzed by immunoblotting at the 592 indicated time points. -actin served as a loading control. Relative EBV titer of lytically induced 593 Akata-BX1 (EBV+) cells carrying SAMHD1-deletion or control was measured using a Raji cell 594 infection assay. 595 (C) SAMHD1 depletion facilitates EBV replication in P3HR-1 cells. SAMHD1-depleted (sg-1 596 and sg-2) and control (sg-NC) P3HR-1cells were treated with TPA and Sodium Butyrate (NaBu) 597 to induce EBV lytic reactivation. Western blots were performed using antibodies as indicated. -598 actin served as a loading control. Relative EBV DNA copy numbers were determined by qPCR 599 using primers to BALF5 gene normalized by -actin.
600
(D) BGLF4 knockdown suppresses EBV replication in SAMHD1-expressing cells but not in 601 SAMHD1-depleted cells. Control (sg-NC) and SAMHD1-depleted (sg-1) Hela (EBV+) cells 602
were transfected with ZTA plus RTA to induce EBV lytic reactivation. The siBGLF4-expressing 603 plasmid was co-transfected to knockdown BGLF4. The transfection of si-NC served as a 604 negative control for siBGLF4. The EBV genome copy numbers were measured by qPCR using 605 primers specific to EBV BALF5 gene normalized by β-actin.
606
Representative results from three biological replicates are presented. Error bars indicate the 607 standard deviation. * p < 0.05; n.s.: not significant. See also Figure S1 . analysis.
Step 1: Recombinant SAMHD1 was phosphorylated by BGLF4 or CDK1 in vitro. Non-623 phosphorylated SAMHD1 was similarly processed by incubating with kinase-dead BGLF4 624 (BGLF4-KD) or Buffer control.
Step 2: The phosphorylated and non-phosphorylated SAMHD1 625 were converted to GTP-bound dimer.
Step 3: SAMHD1 dimer was further activated by adding 626 dNTP mix for 60 sec.
Step 4: The mixture was diluted 10-fold and the substrate dCTP is added 627 for 0 to 240 min. For analysis of other dNTP hydrolysis, 100 M dTTP, dATP or dGTP was 628 added in Step 4. 629 (B) The SAMHD1 dNTPase activity (dN generation rate, pmol dN/pmol-SAMHD1/min) was 630 analyzed by HPLC using a Synergi C18 column 150 x 4.6 mm. Error bars represent the standard 631 error of the mean from two independent experiments. * p<0.05; n.s.: not significant. determined by quantitative PCR using primer to BALF5 gene normalized by -actin.
674
Representative results from three biological replicates are presented. 
